Journal
NATURE REVIEWS MICROBIOLOGY
Volume 4, Issue 12, Pages 932-942Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrmicro1552
Keywords
-
Categories
Funding
- NIAID NIH HHS [U01 AI060603-03, U01 AI060603] Funding Source: Medline
Ask authors/readers for more resources
An ongoing public health challenge is to develop vaccines that are effective against infectious diseases that have global relevance. Vaccines against serotypes of group B Streptococcus ( GBS) that are prevalent in the United States and Europe are not optimally efficacious against serotypes common to other parts of the world. New technologies and innovative approaches are being used to identify GBS antigens that overcome serotypespecificity and that could form the basis of a globally effective vaccine against this opportunistic pathogen. This Review highlights efforts towards this goal and describes a template that can be followed to develop vaccines against other bacterial pathogens.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available